Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KL0011034 Injection in Healthy Non-Elderly and Elderly Trial Participants
NCT07913048Phase 1Not yet recruiting
- Sponsor
- Hunan Kelun Pharmaceutical
- Start
- Nov 2026
- Primary completion
- Nov 2026
- Countries
- 1
01
Overview
Phase 1, open-label trial of KL0011034 (2 arms), sponsored by Hunan Kelun Pharmaceutical. Primary endpoints: Maximum Plasma Concentration, Time to Maximum Plasma Concentration and 3 more. Planned start Nov 2026; status: not yet recruiting.
02
Drugs
KL0011034
Beyond the preview
Go deeper on NCT07913048.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07913048.